INVIVO THERAPEUTICS HOLDINGS CORP.·4

Dec 23, 5:23 PM ET

Toselli Richard M. 4

4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Dec 23, 2019

Insider Transaction Report

Form 4
Period: 2019-12-19
Toselli Richard M.
Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-12-19$0.16/sh557$8978,986 total
Footnotes (1)
  • [F1]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligations applicable to the vesting of 1,500 stock-settled restricted stock units ("RSUs"). The vesting schedule for the RSUs was amended on June 11, 2019, and the remaining shares underlying the unvested RSUs vest in equal semi-annual installments on June 18 and December 18 until fully vested on December 18, 2021.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -